跳至主要内容
临床试验/NCT07584447
NCT07584447尚未招募不适用

Clinical Utility of Preoperative Thyroid GuidePx® Testing

University of Calgary0 个研究点目标入组 85 人开始时间: 2026年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
85

研究概览

简要总结

The purpose of this study is to learn whether having Thyroid GuidePx® test results available before treatment may help patients with papillary thyroid cancer and doctors make better-informed treatment decisions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 years or older at the time of enrollment
  • English-speaking
  • Bethesda V or VI cytology following FNA of a thyroid nodule (papillary thyroid cancer)
  • Bethesda III or IV with ThyroSpec positive for BRAFV600E, TERT, rearrangements in BRAF, RET, NTRK1, NTRK3, RAS + TERT, RAS + EIF1AX, AKT1, PI3CA, CTNNB1, EGFR, rearrangements in ALK
  • Tumor 1- 4cm in size
  • No lymph node involvement on ultrasound
  • No gross extrathyroidal extension on ultrasound

排除标准

  • Prior thyroid operation
  • Distant metastatic disease
  • Personal history of thyroid cancer
  • History of whole-body radiation exposure or radiation to the head and neck region

研究者

申办方类型
Other
责任方
Sponsor

相似试验